NuLine Clinical Trial

05/25/2026

12/03/2024

The purpose of this study is to determine the safety, metabolism and potential effect of drug product SFA004 on mild to moderate chronic plaque psoriasis. Psoriasis is a common chronic skin disorder that affects over 4 million people. There is no cure for psoriasis and treatment is directed at controlling patients' symptoms.

The purpose of this study is to determine the safety, metabolism and potential effect of drug product SFA004 on mild to moderate chronic plaque psoriasis. Psoriasis is a common chronic skin disorder that affects over 4 million people. There is no cure for psoriasis and treatment is directed at cont....

11/26/2024

At NuLine Clinical Trial, we prioritize precision and patient safety by equipping our facilities with state-of-the-art technology like ultra-low freezers, refrigerated centrifuges, incubators, and spirometers. This advanced equipment ensures reliable data and supports diverse studies in fields such as dermatology and psychiatry. Our commitment to innovation drives better healthcare solutions for all.